Welcome to our dedicated page for Cellebrite Di news (Ticker: CLBT), a resource for investors and traders seeking the latest updates and insights on Cellebrite Di stock.
Cellebrite DI Ltd (NASDAQ: CLBT) provides authoritative digital intelligence solutions to law enforcement and enterprises worldwide. This news hub offers investors and professionals a centralized resource for tracking corporate developments, technological advancements, and strategic initiatives shaping the digital forensics sector.
Access timely updates including earnings reports, product launches, partnership announcements, and regulatory filings. Our curated collection ensures stakeholders stay informed about critical developments affecting investigative technology markets, cybersecurity trends, and Cellebrite’s position as a leader in legally sanctioned data analysis solutions.
Key updates cover innovations in mobile device forensics, cloud data extraction tools, and enterprise-grade investigative platforms. Regular monitoring of this page provides insights into Cellebrite’s subscription revenue growth, global expansion efforts, and responses to evolving data privacy regulations.
Bookmark this page for structured access to CLBT’s official communications and third-party analysis. Combine technical understanding of digital intelligence markets with strategic business insights through our maintained news archive.
Cellebrite (NASDAQ: CLBT) announced its Q1 2024 results, reporting a 27% year-over-year increase in Annual Recurring Revenue (ARR) to $331.8 million. Q1 2024 revenue rose by 26% to $89.6 million, driven by a 29% growth in subscription revenue. The company recorded a GAAP net loss of $71.4 million and a non-GAAP net income of $16.9 million. Adjusted EBITDA stood at $17.6 million with a 19.7% margin. CEO Yossi Carmil emphasized the global expansion and profitability improvements, noting the positive reception of new products like the Inseyets digital forensics software. The company reaffirmed its outlook for 2024, expecting ARR between $380 million and $400 million, and revenue between $370 million and $380 million for the full year.
Cellebrite (NASDAQ: CLBT), a global leader in digital investigative solutions, announced its participation in several investor conferences from May 26 to June 5, 2024. The company will engage in various formats, including fireside chats, 1x1 meetings, and presentations.
Key dates include May 26 at the Oppenheimer 25th Annual Israeli Conference, May 29 at the Craig-Hallum Institutional Investor Conference, May 30 at the TD Cowen 52nd Annual Technology, Media & Telecom Conference, and June 5 at the William Blair 44th Annual Growth Stock Conference.
Cellebrite executives like Dana Gerner (CFO), Andrew Kramer (VP), and Yossi Carmil (CEO) will present at these events. The conferences are opportunities for the company to highlight its digital investigative solutions and connect with investors.
FAQ
What is the current stock price of Cellebrite Di (CLBT)?
What is the market cap of Cellebrite Di (CLBT)?
